Navigation Links
Longitudinal Study Highlights Evolving Role of Medical Science Liaisons with Thought Leaders and Product Development
Date:3/1/2013

CHAPEL HILL, N.C., March 1, 2013 /PRNewswire/ -- While medical science liaisons have been around for more than 40 years, the role and activities of these medical specialists have grown quickly over the last decade. The pharmaceutical industry has long relied on medical science liaisons to forge relationships with key opinion leaders (KOLs) who can provide critical insights into the market and competition.

But the changing regulatory and access environment has altered the landscape for creating and maintaining KOL and physician relationships.

To help organizations navigate this new KOL landscape, research and consulting leader Best Practices LLC published a MSL-focused report that highlights their key pre- and post-launch activities, and service frequencies. The 78-page report presents 2011 data compared to 2009 on an array of critical activities that provide insights into how MSLs can build strong, productive relationships with KOLs and physicians. 

"Roles, Resourcing and Management of Medical Science Liaisons" provides MSL leaders with key metrics to help them create and maintain an effective MSL group. The comparative structure of the report (2011 data vs. 2009 data) also opens a window to emerging trends that will enable leaders in medical affairs – the group where MSL operations are typically housed - to set a clear direction for their MSL group going forward.

For instance, the study shows companies in 2011 were having managers oversee a greater number of MSLs than they did in 2009. In 2011, 57 percent of respondents preferred to have one manager overseeing 7-10 specialists. In 2009, the preferred span-of-control was one manger to up to six specialists (47 percent).

The key topics covered in this report include:


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New Study Shows Cannabis Effects on Driving Skills
2. Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis
3. University Hospitals Case Medical Center Presents Study On The Elimination Of Retained Surgical Sponges
4. MD+DI, the Global MedTech Authority, Publishes One-of-a-Kind Study with ITG Market Research on the Medical Device Outsourcing Landscape
5. New Direct-to-Consumer Prescription Delivery Channel Mitigates Risk of Medication Non-Adherence Highlighted in JAMA Internal Medicine Study
6. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting
7. Study Shows Medicare Savings When Local Pharmacies Fill 90-Day Prescriptions
8. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
9. Adynxx Enrolls First Patient in Phase 2 Proof-of-Concept Study for AYX1, Lead Compound for the Prevention of Post-Surgical Pain
10. First U.S. Patients Treated in PneumRx RENEW Pivotal Study for Treatment of Severe Emphysema
11. New Study Results Published in the New England Journal of Medicine Show Dabigatran Etexilate Mesylate Reduces the Risk of Recurrent Venous Thromboembolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... BOCA RATON, Fla. , Sept. 2, 2015 ... Cartledge , MD, FACS, has begun performing ultra-minimally ... patients who are on anticoagulants such as Coumadin, ... of Cardiothoracic Surgery at the Hospital, is one ... this method, which involves making two microscopic incisions ...
(Date:9/2/2015)... , September 2, 2015 ... Market by Product (Digital & Computed Radiography, Ultrasound, Computed ... Radiology, PACS) by Application (Oncology, Cardiology, Neurology) - Global ... Poised to reach USD 2.8 Billion by 2020 growing ... Br owse 240 Tables and ...
(Date:9/2/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... on tissue protection, repair and regeneration, today announced ... Executive Officer, will present a corporate overview at ... by H.C. Wainwright & Co.  The ... the St. Regis Hotel in New York City.   ...
Breaking Medicine Technology:Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 2Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 3Veterinary Imaging Market Worth USD 2.8 Billion by 2020 2Veterinary Imaging Market Worth USD 2.8 Billion by 2020 3Veterinary Imaging Market Worth USD 2.8 Billion by 2020 4Veterinary Imaging Market Worth USD 2.8 Billion by 2020 5RegeneRx to Present at Rodman & Renshaw Global Investment Conference 2RegeneRx to Present at Rodman & Renshaw Global Investment Conference 3
... Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced ... trial evaluating the safety and pharmacokinetics of dabigatran ... valves.(1) The 12-week study will compare three doses ... 300mg bid) to warfarin in patients with both ...
... What is the state of medical innovation in this new ... developed to treat heart disease? Is cardiovascular innovation still a ... industry see as the biggest opportunities?  Will IBM,s Watson supercomputer ... These questions – and many others – will ...
Cached Medicine Technology:Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 2Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 4Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 5Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 6Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 72011 Medical Innovation Summit to Showcase Latest Innovations in Cardiovascular Care 22011 Medical Innovation Summit to Showcase Latest Innovations in Cardiovascular Care 3
(Date:9/2/2015)... ... 02, 2015 , ... The Hydration Room, Orange County’s first ... second location this week at 31542 S. Coast Hwy, Suite #4, Laguna Beach, ... for patients to relax while receiving safe and effective therapies. Also offering complimentary ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... companies, has completed a recapitalization with new investment partners Beecken Petty O’Keefe ... Group each offer extensive expertise and connections within the healthcare industry, which ...
(Date:9/2/2015)... ... September 02, 2015 , ... The ... two day international investment and business conference will be hosted at five star ... China. The full-weekend networking conference will feature leading EB-5 industry professionals and Chinese ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... patented products, announces Hand Free Pocket Cop, a safety invention that protects people ... US is worth $31 billion," says Scott Cooper, CEO and Creative Director of ...
(Date:9/2/2015)... ... September 02, 2015 , ... EDAC Systems, Inc., a leading ... and services to both government and commercial clients, today announced the release of ... IBM’s Datacap document capture platform. EDAC PurePAGE processes and enhances the images ...
Breaking Medicine News(10 mins):Health News:The Hydration Room Opens New Location In Laguna Beach, California 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 4Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3
... for ambulatory care ... ... Cardiac Science,Corporation, (Nasdaq: CSCX ), a leading provider of ... of its HeartCentrix(R) ECG informatics software with Greenway,Medical Technology,s PrimeSuite(R) ...
... to US$5.5 million -, BELLEVILLE, ON, Dec. ... a research-based, technology-driven Canadian,biopharmaceutical company, today announced that ... its long-term convertible debt with Laurus Master,Funds., ... will now have a maximum,borrowing limit of US$5.5 ...
... Upon an ex parte motion,by the Service ... order (TRO) was issued late on Thursday, December ... County, Michigan,enjoining the Michigan Department of Community Health, ... Carlyle Group from taking certain actions related to,completing ...
... 20 Percent of Cost for New Hospital, SAN ... has reached its $50 million Capital Campaign,goal, the largest ... recent gift of $500,000 from the Stephen and Mary ... http://www.newscom.com/cgi-bin/prnh/20071220/DC10448 ), "It,s only fitting that ...
... For ... Breast Cancer Research., NEWPORT NEWS, Va., Dec. 20 ... Inc. of San Diego,California have settled their lawsuit over Dilon,s ... Dilon in the U.S.,District Court for the Southern District of ...
... gives DRAXIMAGE strong competitive position ... MONTREAL, Dec. 20 /PRNewswire-FirstCall/ - DRAXIMAGE, the,radiopharmaceutical ... (NASDAQ:,DRAX), has appointed GE Healthcare, an industry ... of DRAXIMAGE(R) Sestamibi in the United,States. DRAXIMAGE(R) ...
Cached Medicine News:Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies 2Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies 3Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies 4Health News:Bioniche Amends Terms of Convertible Debt with Laurus Master Funds 2Health News:Manor Care To Vigorously Contest TRO 2Health News:Sharp HealthCare Foundation Reaches $50 Million Goal 2Health News:Sharp HealthCare Foundation Reaches $50 Million Goal 3Health News:DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA 2Health News:DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA 3Health News:DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA 4Health News:DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA 5Health News:DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA 6Health News:DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA 7
... Accurately tests for Nystagmus when ... 10" high by 8" diameter. Light ... ball bearings for effortless spin mechanism. ... from patient. Includes both Adult and ...
Diagnose dry eye, assess the effectiveness of permanent punctal occlusion, collagen - dissolvable in 3-5 days, all are 2 mm long. Sterile...
Clear Base Stand Magnifiers are ideal for any visual task that requires high magnification....
Contour design eyelid implants....
Medicine Products: